Recombinant VP1 Protein Suppresses Liver Cancer Growth
Author Information
Author(s): Chen Tai-An, Wang Jui-Ling, Hung Shao-Wen, Cheng Chiao-Li, Liang Yung-Chih, Lee Shu-Mei
Primary Institution: Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan
Hypothesis
Can recombinant VP1 induce apoptosis and inhibit metastasis in hepatocellular carcinoma?
Conclusion
Recombinant VP1 effectively suppresses the growth and metastasis of liver cancer by inducing apoptosis and reducing CCL2 production.
Supporting Evidence
- rVP1 treatment inhibited cell proliferation in HCC cell lines.
- rVP1 induced apoptosis through Akt deactivation.
- Intratumoral delivery of rVP1 reduced tumor growth in mice.
- rVP1 decreased serum levels of CCL2 in treated mice.
- High doses of rVP1 led to complete tumor regression in some mice.
Takeaway
A special protein from a virus can help stop liver cancer from growing and spreading by making cancer cells die.
Methodology
The study used murine models of hepatocellular carcinoma to test the effects of rVP1 on tumor growth and apoptosis.
Limitations
The study primarily used murine models, which may not fully replicate human responses.
Participant Demographics
BALB/c mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website